Ultrasound vs MRI for Fibroids: Which Test Gives You Better Information?

⚕️ Medical note: This article is for informational purposes only and does not constitute medical advice. No lifestyle approach has been proven to shrink or eliminate uterine fibroids. Please consult a qualified gynecologist or healthcare provider for diagnosis and treatment options. If you are experiencing severe symptoms, seek prompt medical care.

Both ultrasound and MRI are used to diagnose and evaluate fibroids — but they provide different information and are used in different clinical contexts. Understanding the difference helps you ask the right questions about your own diagnostic picture.

Ultrasound: The First-Line Standard

Pelvic ultrasound — and specifically transvaginal ultrasound (TVUS) — is the standard first-line imaging for fibroids. It is widely available, safe, quick, and provides good information about fibroid size, number, and approximate location. For most women, an initial ultrasound combined with a thorough clinical history is sufficient for diagnosis and initial management planning.

Transvaginal ultrasound consistently outperforms transabdominal (over the abdomen) ultrasound for fibroid characterisation — better resolution, more detail about the endometrial cavity, and better detection of smaller submucosal fibroids. If you have only had a transabdominal ultrasound and submucosal involvement is suspected, requesting a TVUS is reasonable. See our full guide on how fibroids are diagnosed.

When Ultrasound Is Limited

Ultrasound has specific limitations: it is less reliable for mapping complex fibroid distributions (multiple fibroids of varying sizes in different locations), it cannot always clearly classify borderline submucosal involvement, and it provides less information about relationships to adjacent structures (bowel, bladder, ureter) in complex cases. Image quality also varies with body habitus.

MRI: When It Adds Value

MRI provides by far the most detailed fibroid mapping — precise size, exact location, relationship to the endometrial cavity, vascularity, and relationship to adjacent structures. It is used when: surgical planning requires precise mapping of all fibroids, UFE (uterine fibroid embolisation) is being planned (MRI guides the procedure and predicts outcomes), there is uncertainty about whether a mass is a fibroid or something else, or when multiple fibroids make ultrasound characterisation unreliable.

MRI is also the best tool for detecting adenomyosis — a condition that often co-exists with fibroids and can complicate both diagnosis and treatment planning.

Sonohysterography: The Middle Option

Saline infusion sonohysterography (SIS) — where sterile saline is injected into the uterine cavity during transvaginal ultrasound — provides much better visualisation of the cavity than standard ultrasound without MRI cost. It is particularly useful for characterising submucosal fibroid type (Type 0, 1, or 2) and distinguishing fibroids from polyps. Worth requesting if submucosal involvement needs clarification before treatment decisions. See our article on submucosal fibroids explained for context on why this classification matters.

Track it, then talk to your doctor: A simple diary of bleeding, pain and other symptoms over one or two cycles gives your doctor far better information – see how to track your fibroid symptoms. Very heavy bleeding, severe pain, feeling faint or short of breath need prompt medical attention; the NHS and the Office on Women’s Health explain when to seek help.

Read next If you want to understand the hormonal side of this, how estrogen drives fibroid growth — and what shifts it.